Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Sangel Capital, officially known as Shenzhen Sangel Venture Capital Co., Ltd., is one of the earliest professional biomedical venture capital firms in China. Founded in 2010 and headquartered in Shenzhen, the firm has established a prominent position in the biomedical investment industry. Sangel Capital operates globally, with offices in Shenzhen, Beijing, Suzhou, and Chicago, managing a series of RMB and USD funds. The firm leverages extensive project resources and expertise in life sciences to support its portfolio companies.
Over the years, Sangel Capital has built a reputation for its long-term investment approach, focusing on cultivating industry benchmarks in promising sectors. The firm has achieved notable milestones, including successful IPOs of portfolio companies such as Huaheng Biotech and Sirnaomics Ltd. Sangel Capital's commitment to the life sciences sector positions it as a key player in the global investment landscape.
Sangel Capital specializes in investments within the life sciences sector, targeting innovative growth enterprises with significant capital value and commercial potential. The firm emphasizes original innovation and core technological assets, focusing on biomedicine, medical devices, healthcare, and pharmaceuticals. Sangel Capital adopts a long-term investment philosophy, prioritizing value creation over mere exit strategies.
The firm seeks to cultivate industry benchmarks in promising industries globally, particularly in Asia. Sangel Capital's investment strategy includes a focus on seed and early-stage companies, allowing it to engage with startups at critical growth phases. The firm values founders who demonstrate a strong vision and commitment to advancing healthcare solutions.
Sangel Capital has invested in over 70 notable companies in the life sciences sector, showcasing a diverse portfolio that includes:
Liu Mulong: Founding Partner; recognized as one of China's top early-stage investors by ChinaVenture Awards in 2021. Liu has a strong background in biomedical investments and emphasizes a long-term investment philosophy.
To pitch Sangel Capital, founders should use the preferred channel of their website or email. It is essential to include a comprehensive deck that outlines the business model, market opportunity, and team qualifications. Sangel Capital values thoroughness and clarity in presentations.
Response times may vary, but founders can expect to hear back within a few weeks. Warm introductions are beneficial but not mandatory. The firm encourages direct outreach from passionate founders with innovative ideas.
In September 2022, Liu Mulong received recognition as one of China's top early-stage investors from ChinaVenture Awards. Sangel Capital has been active in the biomedical investment space, focusing on life sciences and engaging with notable companies. Recent portfolio highlights include Funo Biotech, recognized in the 2021 Venture50 list, and Suyuan Biotech, which is collaborating with QIAGEN on diagnostic kits.
What are Sangel Capital's investment criteria?
Sangel Capital focuses on the life sciences sector, targeting innovative growth enterprises with significant capital value and commercial potential. The firm seeks companies that demonstrate original innovation and core technological assets.
How can I apply or pitch to Sangel Capital?
Founders can pitch to Sangel Capital through their website at sangelvc.com or via email at sangel@sangelvc.com. It is advisable to include a comprehensive business plan and details about the team and technology.
What makes Sangel Capital different from other VC firms?
Sangel Capital is one of the earliest specialized biomedical VC firms in China, emphasizing a long-term investment philosophy and focusing exclusively on the life sciences sector. This specialization allows them to provide deep industry expertise and resources to their portfolio companies.
What is Sangel Capital's geographic scope?
The firm operates globally, with a strong emphasis on the Asian market. Its offices in Chicago also facilitate cross-border investments and collaborations.
What is Sangel Capital's approach to post-investment involvement?
Sangel Capital provides significant value to its portfolio companies through extensive industry expertise, project resources, and a long-term investment approach. The firm actively engages with its companies to enhance growth opportunities.
What is the typical fund size or check size for Sangel Capital?
While specific fund sizes and check ranges are not disclosed, Sangel Capital manages a series of RMB and USD funds, indicating a capacity to support various stages of investment.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.